BlueWind Medical Begins Enrollment in Tibial Neuromodulator Trial

BlueWind Medical has announced that it is enrolling patients in a late-stage trial of RENOVA iStim, an implantable tibial neuromodulation system, for the treatment of overactive bladder.

The trial will include approximately 200 female participants at 15 study sites in the U.S. and Europe and will study the neuromodulator’s safety and efficacy in improving urinary urgency and incontinence.

Inserted into the ankle in a minimally invasive procedure, the miniature implant is powered by a cuff worn for 30 minutes to 60 minutes a day.